|Bid||683.55 x 0|
|Ask||683.70 x 0|
|Day's range||682.60 - 699.50|
|52-week range||250.85 - 731.50|
|Beta (5Y monthly)||1.50|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||10.00 (1.42%)|
|Ex-dividend date||06 Aug 2020|
|1y target est||N/A|
The big shareholder groups in Clinuvel Pharmaceuticals Limited ( ASX:CUV ) have power over the company. Institutions...
Over the weekend Sanjeev Gupta’s company announced that Swedish firm SSAB was negotiating with Tata over buying its assets in the Netherlands.
Reports emerged on Saturday that the company is in talks with Swedish rival SSAB over the sale of its Dutch businesses. A fact that might throw into doubt the future of the UK’s largest steelworks.